Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy

Fig. 2

When amine oxidase copper-containing 3 (AOC3) on the retinal endothelium binds to the AOC3 counter receptor on the leukocyte, aldehydes, ammonia, and reactive oxygen species are released, which contribute to inflammation. Leukostasis is triggered and leukocytes rupture the blood vessel leading to ischemia. Soluble AOC3 does not mediate leukostasis but contributes to the release of ammonia and reactive oxygen species. RBC red blood cell

Back to article page